Amlodipine/benazepril detailed information

Jump to: navigation, search
Amlodipine/benazepril detailed information
File:Amlodipine.svg
File:Benazepril.svg
Combination of
AmlodipineCalcium channel blocker
BenazeprilACE inhibitor
[[{{{component3}}}]]? Class
[[{{{component4}}}]]? Class
[[{{{component5}}}]]? Class
Clinical data
Pregnancy
category
  • C (first trimester), D (second trimester) (US)
Routes of
administration
Oral
Legal status
Legal status
Identifiers
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).

WikiDoc Resources for Amlodipine/benazepril detailed information

Articles

Most recent articles on Amlodipine/benazepril detailed information

Most cited articles on Amlodipine/benazepril detailed information

Review articles on Amlodipine/benazepril detailed information

Articles on Amlodipine/benazepril detailed information in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Amlodipine/benazepril detailed information

Images of Amlodipine/benazepril detailed information

Photos of Amlodipine/benazepril detailed information

Podcasts & MP3s on Amlodipine/benazepril detailed information

Videos on Amlodipine/benazepril detailed information

Evidence Based Medicine

Cochrane Collaboration on Amlodipine/benazepril detailed information

Bandolier on Amlodipine/benazepril detailed information

TRIP on Amlodipine/benazepril detailed information

Clinical Trials

Ongoing Trials on Amlodipine/benazepril detailed information at Clinical Trials.gov

Trial results on Amlodipine/benazepril detailed information

Clinical Trials on Amlodipine/benazepril detailed information at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Amlodipine/benazepril detailed information

NICE Guidance on Amlodipine/benazepril detailed information

NHS PRODIGY Guidance

FDA on Amlodipine/benazepril detailed information

CDC on Amlodipine/benazepril detailed information

Books

Books on Amlodipine/benazepril detailed information

News

Amlodipine/benazepril detailed information in the news

Be alerted to news on Amlodipine/benazepril detailed information

News trends on Amlodipine/benazepril detailed information

Commentary

Blogs on Amlodipine/benazepril detailed information

Definitions

Definitions of Amlodipine/benazepril detailed information

Patient Resources / Community

Patient resources on Amlodipine/benazepril detailed information

Discussion groups on Amlodipine/benazepril detailed information

Patient Handouts on Amlodipine/benazepril detailed information

Directions to Hospitals Treating Amlodipine/benazepril detailed information

Risk calculators and risk factors for Amlodipine/benazepril detailed information

Healthcare Provider Resources

Symptoms of Amlodipine/benazepril detailed information

Causes & Risk Factors for Amlodipine/benazepril detailed information

Diagnostic studies for Amlodipine/benazepril detailed information

Treatment of Amlodipine/benazepril detailed information

Continuing Medical Education (CME)

CME Programs on Amlodipine/benazepril detailed information

International

Amlodipine/benazepril detailed information en Espanol

Amlodipine/benazepril detailed information en Francais

Business

Amlodipine/benazepril detailed information in the Marketplace

Patents on Amlodipine/benazepril detailed information

Experimental / Informatics

List of terms related to Amlodipine/benazepril detailed information


Amlodipine/benazepril, marketed in the U.S. as Lotrel by Novartis and manufactured as a generic drug by Teva, is an antihypertensive medication which combines a calcium channel blocker (amlodipine besylate) with an angiotensin converting enzyme inhibitor (benazepril). This combination agent, and other analogs, is prescribed when either agent alone is not sufficient to bring a person's blood pressure down to target range. As a combination agent, Lotrel shares the adverse reaction profile of both of its individual parts.

External links



Linked-in.jpg